BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 21611203)

  • 1. IGF1R signaling in Ewing sarcoma is shaped by clathrin-/caveolin-dependent endocytosis.
    Martins AS; Ordóñez JL; Amaral AT; Prins F; Floris G; Debiec-Rychter M; Hogendoorn PC; de Alava E
    PLoS One; 2011; 6(5):e19846. PubMed ID: 21611203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor I receptor pathway inhibition by ADW742, alone or in combination with imatinib, doxorubicin, or vincristine, is a novel therapeutic approach in Ewing tumor.
    Martins AS; Mackintosh C; Martín DH; Campos M; Hernández T; Ordóñez JL; de Alava E
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3532-40. PubMed ID: 16740780
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the IGF1R/PI3K/AKT Pathway Sensitizes Ewing Sarcoma to BET Bromodomain Inhibitors.
    Loganathan SN; Tang N; Holler AE; Wang N; Wang J
    Mol Cancer Ther; 2019 May; 18(5):929-936. PubMed ID: 30926641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flotillin and AP2A1/2 Promote IGF-1 Receptor Association with Clathrin and Internalization in Primary Human Keratinocytes.
    Dam DHM; Jelsma SA; Yu JM; Liu H; Kong B; Paller AS
    J Invest Dermatol; 2020 Sep; 140(9):1743-1752.e4. PubMed ID: 32027876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway.
    Lagares-Tena L; García-Monclús S; López-Alemany R; Almacellas-Rabaiget O; Huertas-Martínez J; Sáinz-Jaspeado M; Mateo-Lozano S; Rodríguez-Galindo C; Rello-Varona S; Herrero-Martín D; Tirado OM
    Oncotarget; 2016 Aug; 7(35):56889-56903. PubMed ID: 27487136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Picropodophyllin inhibits the growth of Ewing's sarcoma cells through the insulin‑like growth factor‑1 receptor/Akt signaling pathway.
    Wu YT; Wang BJ; Miao SW; Gao JJ
    Mol Med Rep; 2015 Nov; 12(5):7045-50. PubMed ID: 26323364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Combination CDK4/6 and IGF1R Inhibitor Strategy for Ewing Sarcoma.
    Guenther LM; Dharia NV; Ross L; Conway A; Robichaud AL; Catlett JL; Wechsler CS; Frank ES; Goodale A; Church AJ; Tseng YY; Guha R; McKnight CG; Janeway KA; Boehm JS; Mora J; Davis MI; Alexe G; Piccioni F; Stegmaier K
    Clin Cancer Res; 2019 Feb; 25(4):1343-1357. PubMed ID: 30397176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formation of the IGF1R/CAV1/SRC tri-complex antagonizes TRAIL-induced apoptosis in gastric cancer cells.
    Guo T; Xu L; Che X; Zhang S; Li C; Wang J; Gong J; Ma R; Fan Y; Hou K; Zhou H; Hu X; Liu Y; Qu X
    Cell Biol Int; 2017 Jul; 41(7):749-760. PubMed ID: 28403518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of G Protein-Coupled Receptor Kinase 2 Promotes Unbiased Downregulation of IGF1 Receptor and Restrains Malignant Cell Growth.
    Crudden C; Shibano T; Song D; Dragomir MP; Cismas S; Serly J; Nedelcu D; Fuentes-Mattei E; Tica A; Calin GA; Girnita A; Girnita L
    Cancer Res; 2021 Jan; 81(2):501-514. PubMed ID: 33158816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenetic implications of early growth response 1 in Ewing sarcoma.
    Noh BJ; Jung WW; Kim HS; Park YK
    Pathology; 2019 Oct; 51(6):605-609. PubMed ID: 31466866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecularly Defined Subsets of Ewing Sarcoma Tumors Differ in Their Responses to IGF1R and WEE1 Inhibition.
    Soni UK; Wang Y; Pandey RN; Roberts R; Pressey JG; Hegde RS
    Clin Cancer Res; 2023 Jan; 29(2):458-471. PubMed ID: 36394520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R1507, an anti-insulin-like growth factor-1 receptor (IGF-1R) antibody, and EWS/FLI-1 siRNA in Ewing's sarcoma: convergence at the IGF/IGFR/Akt axis.
    Huang HJ; Angelo LS; Rodon J; Sun M; Kuenkele KP; Parsons HA; Trent JC; Kurzrock R
    PLoS One; 2011; 6(10):e26060. PubMed ID: 22022506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewing's sarcoma cells by modulating PKCalpha phosphorylation.
    Tirado OM; MacCarthy CM; Fatima N; Villar J; Mateo-Lozano S; Notario V
    Int J Cancer; 2010 Jan; 126(2):426-36. PubMed ID: 19609943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EphA2-induced angiogenesis in ewing sarcoma cells works through bFGF production and is dependent on caveolin-1.
    Sáinz-Jaspeado M; Huertas-Martinez J; Lagares-Tena L; Martin Liberal J; Mateo-Lozano S; de Alava E; de Torres C; Mora J; Del Muro XG; Tirado OM
    PLoS One; 2013; 8(8):e71449. PubMed ID: 23951165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of MEK/MAPK and PI3-K signaling pathway to the malignant behavior of Ewing's sarcoma cells: therapeutic prospects.
    Benini S; Manara MC; Cerisano V; Perdichizzi S; Strammiello R; Serra M; Picci P; Scotlandi K
    Int J Cancer; 2004 Jan; 108(3):358-66. PubMed ID: 14648701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-arrestins regulate mitogenic signaling and clathrin-mediated endocytosis of the insulin-like growth factor I receptor.
    Lin FT; Daaka Y; Lefkowitz RJ
    J Biol Chem; 1998 Nov; 273(48):31640-3. PubMed ID: 9822622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The adipocyte plasma membrane caveolin functional/structural organization is necessary for the efficient endocytosis of GLUT4.
    Shigematsu S; Watson RT; Khan AH; Pessin JE
    J Biol Chem; 2003 Mar; 278(12):10683-90. PubMed ID: 12496259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutant huntingtin inhibits clathrin-independent endocytosis and causes accumulation of cholesterol in vitro and in vivo.
    Trushina E; Singh RD; Dyer RB; Cao S; Shah VH; Parton RG; Pagano RE; McMurray CT
    Hum Mol Genet; 2006 Dec; 15(24):3578-91. PubMed ID: 17142251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of common and distinctive mechanisms of resistance to different anti-IGF-IR agents in Ewing's sarcoma.
    Garofalo C; Mancarella C; Grilli A; Manara MC; Astolfi A; Marino MT; Conte A; Sigismund S; Carè A; Belfiore A; Picci P; Scotlandi K
    Mol Endocrinol; 2012 Sep; 26(9):1603-16. PubMed ID: 22798295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF1R tyrosine kinase inhibitor enhances the cytotoxic effect of methyl jasmonate in endometrial cancer.
    Bruchim I; Sarfstein R; Reiss A; Flescher E; Werner H
    Cancer Lett; 2014 Oct; 352(2):214-9. PubMed ID: 24997432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.